NUVB Annual EBITDA
-$99.60 M
+$19.93 M+16.68%
31 December 2023
Summary:
As of January 23, 2025, NUVB annual earnings before interest, taxes, depreciation & amortization is -$99.60 million, with the most recent change of +$19.93 million (+16.68%) on December 31, 2023. During the last 3 years, it has fallen by -$56.15 million (-129.24%). NUVB annual EBITDA is now -129.24% below its all-time high of -$43.45 million, reached on December 31, 2020.NUVB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVB Quarterly EBITDA
-$40.93 M
+$421.19 M+91.14%
01 September 2024
Summary:
As of January 23, 2025, NUVB quarterly earnings before interest, taxes, depreciation & amortization is -$40.93 million, with the most recent change of +$421.19 million (+91.14%) on September 1, 2024. Over the past year, it has dropped by -$20.79 million (-103.21%). NUVB quarterly EBITDA is now -355.21% below its all-time high of -$8.99 million, reached on June 1, 2020.NUVB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVB TTM EBITDA
-$560.94 M
-$21.33 M-3.95%
01 September 2024
Summary:
As of January 23, 2025, NUVB TTM earnings before interest, taxes, depreciation & amortization is -$560.94 million, with the most recent change of -$21.33 million (-3.95%) on September 1, 2024. Over the past year, it has dropped by -$462.87 million (-471.97%). NUVB TTM EBITDA is now -5999.79% below its all-time high of -$9.20 million, reached on March 1, 2020.NUVB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.7% | -103.2% | -472.0% |
| 3 y3 years | -129.2% | -80.1% | -625.6% |
| 5 y5 years | -129.2% | -345.1% | -5999.8% |
NUVB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.9% | +16.7% | -108.9% | +91.1% | -516.9% | at low |
| 5 y | 5-year | -129.2% | +16.7% | -355.2% | +91.1% | -5999.8% | at low |
| alltime | all time | -129.2% | +16.7% | -355.2% | +91.1% | -5999.8% | at low |
Nuvation Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$40.93 M(-91.1%) | -$560.94 M(+4.0%) |
| June 2024 | - | -$462.12 M(+2194.4%) | -$539.60 M(+450.2%) |
| Mar 2024 | - | -$20.14 M(-46.6%) | -$98.07 M(-6.1%) |
| Dec 2023 | -$99.60 M(-16.7%) | -$37.75 M(+92.7%) | -$104.39 M(+14.8%) |
| Sept 2023 | - | -$19.59 M(-4.8%) | -$90.93 M(-9.6%) |
| June 2023 | - | -$20.58 M(-22.2%) | -$100.62 M(-14.6%) |
| Mar 2023 | - | -$26.46 M(+9.0%) | -$117.86 M(-1.4%) |
| Dec 2022 | -$119.53 M | -$24.29 M(-17.1%) | -$119.54 M(-4.2%) |
| Sept 2022 | - | -$29.28 M(-22.6%) | -$124.82 M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$37.82 M(+34.4%) | -$118.25 M(+17.3%) |
| Mar 2022 | - | -$28.15 M(-4.8%) | -$100.83 M(+8.3%) |
| Dec 2021 | -$93.13 M(+114.4%) | -$29.57 M(+30.1%) | -$93.13 M(+20.5%) |
| Sept 2021 | - | -$22.72 M(+11.4%) | -$77.31 M(+16.9%) |
| June 2021 | - | -$20.39 M(-0.3%) | -$66.11 M(+20.8%) |
| Mar 2021 | - | -$20.45 M(+48.9%) | -$54.71 M(+25.9%) |
| Dec 2020 | -$43.45 M | -$13.74 M(+19.3%) | -$43.45 M(+46.3%) |
| Sept 2020 | - | -$11.52 M(+28.1%) | -$29.71 M(+63.3%) |
| June 2020 | - | -$8.99 M(-2.2%) | -$18.19 M(+97.8%) |
| Mar 2020 | - | -$9.20 M | -$9.20 M |
FAQ
- What is Nuvation Bio annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Nuvation Bio?
- What is Nuvation Bio annual EBITDA year-on-year change?
- What is Nuvation Bio quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Nuvation Bio?
- What is Nuvation Bio quarterly EBITDA year-on-year change?
- What is Nuvation Bio TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Nuvation Bio?
- What is Nuvation Bio TTM EBITDA year-on-year change?
What is Nuvation Bio annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NUVB is -$99.60 M
What is the all time high annual EBITDA for Nuvation Bio?
Nuvation Bio all-time high annual earnings before interest, taxes, depreciation & amortization is -$43.45 M
What is Nuvation Bio annual EBITDA year-on-year change?
Over the past year, NUVB annual earnings before interest, taxes, depreciation & amortization has changed by +$19.93 M (+16.68%)
What is Nuvation Bio quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NUVB is -$40.93 M
What is the all time high quarterly EBITDA for Nuvation Bio?
Nuvation Bio all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$8.99 M
What is Nuvation Bio quarterly EBITDA year-on-year change?
Over the past year, NUVB quarterly earnings before interest, taxes, depreciation & amortization has changed by -$20.79 M (-103.21%)
What is Nuvation Bio TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NUVB is -$560.94 M
What is the all time high TTM EBITDA for Nuvation Bio?
Nuvation Bio all-time high TTM earnings before interest, taxes, depreciation & amortization is -$9.20 M
What is Nuvation Bio TTM EBITDA year-on-year change?
Over the past year, NUVB TTM earnings before interest, taxes, depreciation & amortization has changed by -$462.87 M (-471.97%)